Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
35.32    1.08 (3.15%)
Bid:
35.38
Ask:
35.46
Spread: 0.08 (0.226%)
Market Cap: £564.77m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Director/PDMR Shareholding

17 Nov 2014 10:04

RNS Number : 1892X
Hays PLC
17 November 2014
 



NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY

 

Hays plc (the "Company")

 

In accordance with Disclosure and Transparency Rule 3.1, the Company hereby notifies the market of the following.

 

Hays plc Performance Share Plan ("PSP")

 

In London on 14 November 2014 the Remuneration Committee granted the following nil cost awards to the PDMRs listed in the table below under the Company's PSP.

 

The PSP is a performance share plan which provides participants with the conditional right, subject to performance conditions being met, to receive ordinary shares of one pence each in the Company. The awards granted in 2014 will be measured against the performance conditions after three financial years commencing 1 July 2014.

 

 

PDMR

NO. OF SHARES AWARDED UNDER PSP

Alistair Cox*

976,666

Paul Venables*

704,175

Nick Cox

336,950

Sholto Douglas-Home

212,607

Doug Evans

251,725

John Faraguna

226,167

Nigel Heap

449,102

Robert Potter

240,770

Steve Weston

231,139

 

* Denotes a Director of the Company.

 

The shares will be released to the PDMRs subject to their continued employment and the satisfaction of the following performance conditions:-

 

· one third based on the Group's Cumulative Earnings Per Share;

· one third based on relative Total Shareholder Return against an agreed comparator group; and

· one third based on Cumulative Cash Conversion.

 

One quarter of each component will vest at threshold performance, rising on a straight line basis to full vesting for maximum performance. For the TSR component one quarter of the shares will vest for median performance, with full vesting for upper quartile performance. Vesting of the TSR component is also subject to satisfactory financial performance, as determined by the Remuneration Committee.

 

The targets for the EPS and Cash Conversion performance conditions will be disclosed in the Company's 2015 Annual Report on Remuneration.

 

Chris Winters

Deputy Company Secretary

Hays plc

 

17 November 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFIILSLDLIS
Date   Source Headline
4th Jun 20262:18 pmRNSDirector/PDMR Shareholding
1st Jun 202611:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSShare buyback programme
27th May 20269:14 amRNSHolding(s) in Company
19th May 20265:00 pmRNSDirector/PDMR Shareholding
18th May 20267:05 amRNSDirector/PDMR Shareholding
18th May 20267:00 amRNSCEO Appointment
1st May 202610:00 amRNSTotal Voting Rights
29th Apr 20264:06 pmRNSDirector/PDMR Shareholding
28th Apr 20269:59 amRNSDirector/PDMR Shareholding
22nd Apr 20262:09 pmRNSHolding(s) in Company
22nd Apr 20262:06 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSThird Quarter Trading Statement
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
1st Apr 202611:00 amRNSTotal Voting Rights
27th Mar 20265:00 pmRNSHolding(s) in Company
27th Mar 20264:11 pmRNSDirector/PDMR Shareholding
25th Mar 202610:05 amRNSDirector/PDMR Shareholding
4th Mar 20261:24 pmRNSDirector/PDMR Shareholding
3rd Mar 20264:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:00 pmRNSDirector/PDMR Shareholding
2nd Mar 202611:00 amRNSTotal Voting Rights
27th Feb 20264:15 pmRNSHolding(s) in Company
27th Feb 20267:01 amRNSCEO departure and succession plan
27th Feb 20267:00 amRNSHalf-Year Report
2nd Feb 202611:00 amRNSTotal Voting Rights
14th Jan 20267:00 amRNSSecond Quarter Trading Statement
5th Jan 20267:00 amRNSCEO update
2nd Jan 202610:00 amRNSTotal Voting Rights
1st Dec 202511:00 amRNSTotal Voting Rights
21st Nov 20253:10 pmRNSDirector/PDMR Shareholding
19th Nov 20252:33 pmRNSResult of AGM
11th Nov 202512:00 pmRNSDirector/PDMR Shareholding
10th Nov 20257:00 amRNSCEO Medical Leave
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 202510:00 amRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 202511:00 amRNSShare buyback programme
10th Oct 20257:00 amRNSFirst Quarter Trading Statement
6th Oct 202512:00 pmRNSPublication of Annual Report and Notice of AGM
3rd Oct 202511:09 amRNSDirector/PDMR Shareholding
1st Oct 202510:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.